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Background: Three-dimensional (3D) culture in porous biomaterials as well as stimulation with growth factors are
known to be supportive for intervertebral disc cell differentiation and tissue formation. Unless sophisticated
releasing systems are used, however, effective concentrations of growth factors are maintained only for a very
limited amount of time in in vivo applications. Therefore, we investigated, if an initial boost with transforming
growth factor-beta 1 (TGF-beta 1) is capable to induce a lasting effect of superior cartilaginous differentiation in
slightly and severely degenerated human annulus fibrosus (AF) cells.
Methods: Human AF tissue was harvested during surgical treatment of six adult patients with lumbar spinal
diseases. Grading of disc degeneration was performed with magnet resonance imaging. AF cells were isolated and
expanded in monolayer culture and rearranged three-dimensionally in a porous biomaterial consisting of stepwise
absorbable poly-glycolic acid and poly-(lactic-co-glycolic) acid and a supportive fine net of non-absorbable polyvinylidene
fluoride. An initial boost of TGF-beta 1 or TGF-beta 1 and hyaluronan was applied and compared with controls. Matrix
formation was assessed at days 7 and 21 by (1) histological staining of the typical extracellular matrix molecules
proteoglycan and type I and type II collagens and by (2) real-time gene expression analysis of aggrecan, decorin,
biglycan, type I, II, III, and X collagens as well as of catabolic matrix metalloproteinases MMP-2 and MMP-13.
Results: An initial boost with TGF-beta 1 or TGF-beta 1 and hyaluronan did not enhance the expression of characteristic
AF matrix molecules in our 3D culture system. AF cells showed high viability in the progressively degrading biomaterial.
Stratification by grade of intervertebral disc degeneration showed that AF cells from both, slightly degenerated,
or severely degenerated tissue are capable of significant up-regulations of characteristic matrix molecules in 3D
culture. AF cells from severely degenerated tissue, however, displayed significantly lower up-regulations in some
matrix molecules such as aggrecan.
Conclusions: We failed to show a supportive effect of an initial boost with TGF-beta 1 in our 3D culture system.
This underlines the need for further investigations on growth factor releasing systems.
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In the interventional and surgical treatment of degenerative
intervertebral disc diseases, there is a need for annulus
fibrosus (AF) repair techniques because they address the
unsolved problem of re-herniation through the untreated
annulus defect after intervertebral disc herniation [1]
and they facilitate the development of nucleus pulposus
augmentation techniques by providing adequate nucleus
containment [2].
Major components of the AF are collagens (60%–70%
of dry weight), mostly type I collagen, and proteoglycans
(15%–20% of dry weight) [3]. These matrix molecules
were shown to have considerably low turnover rates [4,5].
Age and degeneration appear to have distinguishable effects
on the AF [6-8]. The overall proteoglycan concentration,
including the small proteoglycans decorin and biglycan,
seem to decrease with age; whereas with degeneration,
increased proteoglycan concentrations for moderate
and decreased proteoglycan concentrations for severely
degenerated AF are reported. In addition, AF degeneration
is associated with increased type I and III collagen synthe-
sis, an increased expression of inflammatory factors and
matrix-degrading molecules, as well as with a deregulation
of anabolic factors [3,9]. These changes result in a cata-
bolic metabolic state with increasing fibrous transform-
ation, impaired biomechanical function, and the incidence
of AF defects. For biological annular repair techniques, the
choice of a biocompatible and biomechanically suitable
material is crucial [10]. But the additional enhancement of
tissue generation with bioactive factors might be another
important component [11], regardless of whether a cell-free
[12] or a cell-based approach [13,14] is applied.
In a previous work, we reported on the suitability of a
polymer-based absorbable textile scaffold to facilitate the
expression of characteristic matrix molecules of AF cells
in three-dimensional (3D) culture [15]. Moreover, we
showed an anabolic effect of human serum, FGF-2, and
transforming growth factor-beta (TGF-beta) 3 on AF cells
with significantly enhanced expression of characteristic
matrix molecules [11].
In this work, we tested a textile porous biomaterial
consisting of stepwise absorbable poly-glycolic acid (PGA)
and poly-(lactic-co-glycolic) acid (PLGA) and a supportive
fine net of non-absorbable polyvinylidene fluoride (PVDF).
The concept of using an absorbable polymer-based bioma-
terial, supported by a fine PVDF net for primary stability,
revealed promising biomechanical and biocompatibility
characteristics in a cell-free approach for AF defects in
an ovine model [16]. Here, the utility of the PGA-
PLGA-PVDF scaffold for a cell-based approach with
human AF cells from slightly and severely degenerated
lumbar intervertebral discs was investigated. Since TGF-
beta has shown promising results as an anabolic factor for
AF cells [11], we examined the potential of an initial boostwith TGF-beta with and without hyaluronan to enhance
characteristic matrix formation.Materials and methods
Human annulus fibrosus cell preparation and cultivation
Human annulus fibrosus tissue was harvested during
surgical treatment of spondylolistesis (n = 4) or scoliosis
(n = 2). Grading of disc degeneration was performed
using preoperative magnet resonance imaging (MRI) as
described previously [17]. Three out of six donor tissues
were graded as ‘slightly degenerated’ (n = 3 females age
33–43; mean age 40 years, spinal segments: L4/L5, L5/S1,
L5/S1); three out of six donor tissues were graded as
‘severely degenerated’ (n = 3 females, age 38–72; mean
age 61 years, spinal segments: L3/L4, L4/L5, L5/S1).
The ethics committee of University Medical Center
Mannheim approved the study, and informed patient
consent was obtained.
The tissue was minced and digested for 2 h at 37°C in
Dulbecco's modified Eagle's (DME) medium (Biochrom,
Berlin, Germany) containing 10% human serum (German
Red Cross, Berlin, Germany), 2 ng/ml fibroblast growth
factor (PeproTec, Hamburg, Germany), 1.5 U/ml collage-
nase P (Roche, Basel, Switzerland), 500 U/ml collagenase
CLS type II (Biochrom), 50 U/ml hyaluronidase (Sigma,
St. Louis, MO, USA), 100 U/ml penicillin (Biochrom),
100 mg/ml streptomycin (Biochrom) in a spinner flask
under gently stirring. The resulting cell suspension was
poured through a nylon cell strainer (250 μm; BD Falcon,
Franklin Lakes, NJ, USA) and centrifuged at 585 × g.
The cell pellet was washed twice with DME medium
and phosphate-buffered saline (PBS). The annulus fibrosus-
derived cells (AF cells) were counted using trypan blue
(Sigma) dye exclusion and seeded into cell culture flasks
with an initial density of 8,000 cells/cm2. AF cells were
expanded in DME medium supplemented with 10%
human serum and antibiotics as described above. Medium
was changed every 2 to 3 days. After reaching 90% conflu-
ence, AF cells were detached with trypsin/EDTA solution
(Biochrom) and subcultured with a seeding density of
8,000 cells/cm2.3D culture of annulus fibrosus-derived cells
Textile porous scaffolds (3T GmbH, Aachen, Germany)
made of layers of absorbable PGA, PLGA, and PVDF
were sterilized by gamma irradiation (approx. 30 kGy).
PGA-PLGA-PVDF scaffolds (5 mm× 10 mm× 1 mm)
were loaded with either 50 μl sterile water (empty scaffold
serving as control), 2.5 ng transforming growth factor-®1
(TGF-beta 1) in 50 μl sterile water (TGF-beta 1 scaffold),
or 2.5 ng TGF-beta 1 in 50 μl hyaluronan (10 mg/ml,
OSTENIL, TRB Chemedica AG, Munich, Germany) desig-
nated TGF-beta 1-HA scaffold. Scaffolds were freeze-dried
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Germany) and stored in a desiccator at room temperature.
Expanded (passage 3) slightly and severely degenerated
AF cells (pool of n = 3 cell preparations derived from indi-
vidual donors, each) were detached. PGA-PLGA-PVDF
scaffolds were loaded with 1.0 × 106 AF cells mixed with
fibrinogen (Tissucol, Baxter, Westlake Village, CA, USA).
Fibrinogen was polymerized by addition of thrombin
(1:10 v/v in PBS) for 20 min at 37°C. TGF-beta 1 scaffolds
loaded with slightly (n = 4) and degenerated (n = 4) AF
cells, TGF-beta 1-HA scaffolds loaded with slightly (n = 4)
and degenerated (n = 4) AF cells, and empty scaffolds
loaded with slightly (n = 4) and degenerated (n = 4) AF cells
were cultured in 6-well plates for up to 21 days in DME
medium supplemented with 5% human serum, 100 U/ml
penicillin, and 100 mg/ml streptomycin. Medium was
exchanged every 2–3 days.
Real-time gene expression analysis
As described previously [18], total RNA were isolated
from slightly and severely degenerated AF cells expanded in
monolayer cultures (passage 3) and from AF cells cultured
in 3D PGA-PLGA-PVDF scaffolds loaded with TGF-beta
1 or TGF-beta 1-HA or in empty scaffolds. Equal amounts
of total RNA (1 μg) were transcribed into single-stranded
cDNA using the iScript Kit according to the manufacturer's
recommendations (BIO RAD, Munich, Germany). The rela-
tive expression of the housekeeping gene glyceraldehyde-3-
phosphate dehydrogenase (GAPDH) was used to normalize
the cDNA samples. One microliter of each normalized
cDNA sample was analyzed using the SYBR Green PCR
Core Kit (Applied Biosystems, Darmstadt, Germany)
and a real-time PCR Cycler (iCycler; BIO RAD). Expression
levels of genes coding for extracellular matrix molecules
and matrix modifying enzymes (Table 1) were analyzed,
and the fold change (FC) was calculated according to
the ΔΔCT method [19], in comparison to AF cells cultured
in empty PGA-PLGA-PVDF scaffolds or to expandedTable 1 Oligonucleotide sequences
Gene name Accession number Oligonucleotides (5′→
Aggrecan NM_001135 GGC TGC TGT CCC CGT
Biglycan NM_001711 GCT GCC CCT GCT CTC
Collagen type I NM_000088 CGA TGG CTG CAC GAG
Collagen type II NM_001844 CCG GGC AGA GGG CA
Collagen type III NM_000090 GGT TTT GCC CCG TAT
Collagen type X NM_000493 GAA CTC CCA GCA CGC
Decorin NM_001920 ACT TCT GCC CAC CTG
Glyceraldehyde-3-phospate
dehydrogenase
NM_002046 GGC GAT GCT GGC GCT
Matrix metalloproteinase 2 NM_004530 TCC CTG CCC CTC CCT
Matrix metalloproteinase 13 NM_002427 CAA AAA CGC CAG ACmonolayer AF cells. A FC of ≤ −2 or ≥2 was considered
as differential expression.
Histology and immunehistochemistry
For histochemical and immunehistochemical analysis of
proteoglycans and types I and II collagen, AF cells in
PGA-PLGA-PVDF scaffolds were embedded in optimum
cutting temperature (OCT) compound, frozen and
cryo-sectioned (6 μm). Proteoglycans were stained at
pH 2.5 with Alcian blue 8GX (Roth, Germany), followed
by counterstaining with nuclear fast red (Sigma). Collagens
and proteoglycans were visualized by staining with
0.7% Safranin O (Sigma) and counterstaining with 0.2%
Fast Green (Sigma). For detection of collagens, slides
were incubated with rabbit anti-human type I collagen
or anti-human type II collagen antibodies (both Acris,
Heford, Germany) for 40 min. Colorimetrical detection
was done with 3-amino-9-ethylcarbazole (EnVision™,
Dako, Glostrup, Denmark) and counterstaining with
hematoxylin (Merck, Darmstadt, Germany). To evaluate
AF cell viability and distribution within the scaffolds,
propidium iodide/fluorescein diacetate (PI/FDA) staining
(Sigma) was performed as described [20]. Scaffolds loaded
with AF cells were analyzed using a fluorescent microscope
(Olympus AX70, Hamburg, Germany).
Statistics
Gene expression data were analyzed using SigmaStat
3.5 (Systat Software, Erkrath, Germany). The parametric
t test and the non-parametric Mann-Whitney rank sum
test were applied. Differences were considered significant
at p < 0.05.
Results
Human AF cells derived from slightly and severely degen-
erated annulus fibrosus tissue were grown in the presence
of human serum, using standard cell and tissue culture
techniques (Figure 1). During monolayer cell culture and3′), (up/down) Base pairs
AGA AGA/GGG AGG CCA AGT AGG AAG GAT 163
CCA CCA CA/GAA ATG CAT GAG GAG GAG GAA CAG AAC 217
TCA CAC/CAG GTT GGG ATG GAG GGA GTT TAC 180
A TAG CAG GTT/CAA TGA TGG GGA GGC GTG AG 128
TAT GGA/AGT TTC TAG CGG GGT TTT TAC GAG 142
AGA ATC C/GTG TTG GGT AGT GGG CCT TTT ATG 145
GAC ACA ACA C/AAT GGC AGA GCG CAC GTA GAC ACA 128
GAG TAC/TGG TCC ACA CCC ATG ACG A 149
TCA AC/CCT TTC CAG CAG ACA CCA TCA CC 196
A AAT GTG ACC/GAT GCA GGC GCC AGA AGA ATC T 105
Figure 1 Tissue culture of expanded AF cells in 3D scaffolds. Expanded AF cells showed a stretched, fibroblastic morphology when cultured
in monolayers up to passage 3 (A). AF cells were embedded in PGA-PLGA-PVDF scaffolds (B) and maintained viability (green staining) after 7 (C)
and 21 days (D) of tissue culture. At day 7, some dead cells (C, white arrowheads) were evident. Absorbable scaffold fibers (C, white double
arrowhead) showed signs of degradation as early as day 7 and took the red propidium-iodide dye (red staining). The non-absorbable PVDF fibers
took no dye and showed a dark blue color (C, white arrows).
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fibroblast-like morphology of dedifferentiated chondrocytic
cells (Figure 1A). To initiate re-differentiation, expanded
cells (passage 3) were seeded in textile 3D polymer scaf-
folds made of PGA-PLGA and PVDF (Figure 1B) and
cultured for 3 weeks. Life/dead staining (FDA/PI) at day
7 (Figure 1C) and day 21 (Figure 1D) of tissue cultures
revealed mostly viable cells indicated by green staining
and only few red stained cells indicating cell death
(Figure 1C, white arrowhead). Increasing red staining
(PI) by polymer fibers indicated progressive degradation
of absorbable polymer fibers (Figure 1C, white double
arrowhead). The non-absorbable PVDF fibers did not take
up the dye and showed a dark bluish color (Figure 1C,
white arrow).
Effect of initial boost with TGF-beta 1 or TGF-beta
1-hyaluronan
Expanded AF cells were seeded in empty 3D scaffolds and
scaffolds loaded with TGF-beta 1 (50 ng/ml) or TGF-beta
1 (50 ng/ml)-hyaluronan and cultured for 3 weeks without
further addition of TGF-beta 1. Histological analysis of 3D
scaffolds seeded with AF cells showed that AF cells mar-
ginally formed a cartilaginous matrix after 21 days of 3D
culture (Figure 2), independent of an initial boost with
TGF-beta 1 or TGF-beta 1-hyaluronan (data not shown).Alcian blue staining of proteoglycans showed some depos-
ition of proteoglycan (Figure 2A, black arrowhead), but
there was no pronounced staining of extracellular matrix
around AF cells (Figure 2A, black double arrowhead).
Safranin O showed weak staining of a collagenous matrix
but no proteoglycans (Figure 2B, black arrowhead). The
scaffold fibers were fragmented and showed typical signs
of degradation (Figure 2A,B, black arrow). Immune stain-
ing showed collagen type I (Figure 2C, black arrowhead),
but no deposition of collagen type II (Figure 2D). Isotype
controls (IgG) were negative and confirmed specificity of
the immune staining (data not shown).
Gene expression analysis of characteristic AF matrix
molecules and matrix modifying enzymes was performed
at day 7 and day 21 of 3D culture (Figure 3). The initial
boost with TGF-beta 1 on AF cells seeded in the 3D
polymer scaffolds did not influence the expression
profile of aggrecan, biglycan, decorin, collagen types I,
II and X, as well as matrix metalloproteinase (MMP) 2,
compared to non-stimulated 3D cultures. At day 7, but
not at day 21, initial boost stimulation with TGF-beta 1
significantly (p < 0.05) induced the expression of collagen
type III (fold change, FC = 2.0) and MMP13 (FC = 2.8),
compared to non-stimulated controls. After prolonged
culture for 21 days, initial boost stimulation with TGF-
beta 1-hyaluronan significantly (p < 0.05) repressed the
Figure 2 Histological and immunehistochemical staining of AF cells cultured in 3D scaffolds. At day 21, alcian blue staining (A) was weak
and showed marginal deposition of proteoglycans (A, black arrowhead), but there was no pronounced staining of the matrix surrounding AF
cells (A, double arrowhead). Safranin O staining showed no proteoglycans but a weak staining of a collagenous matrix (B, black arrowhead).
Absorbable scaffold fibers took the staining dye and appeared fragmented as a sign of degradation (A, B, black arrows). AF cells stained positively
for type I collagens (C, black arrowheads), while staining for type II collagens were negative (D).
Figure 3 Gene expression analysis of AF cells cultured in 3D scaffolds. Gene expression analysis of AF cells in empty PGA-PLGA-PVDF scaffolds (3D),
scaffolds loaded with TGF-beta 1 (3D TGF), or TGF-beta 1-hyaluronan (3D TGF HA) was performed after 7 and 21 days of tissue culture. Fold changes of
genes coding extracellular matrix molecules and matrix modifying enzymes are given compared to their expression level found in AF cells cultured in empty
scaffolds at day 7 or day 21. Bars show the mean of each triplicate and standard deviation. Asterisks (*) indicate significant differential expression (p< 0.05).
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type X (FC = −2.1), compared to non-stimulated controls.
Effect of grade of intervertebral disc degeneration on AF
cell re-differentiation in 3D culture
To analyze the effect of annulus tissue degeneration on
the re-differentiation capacity of expanded AF cells in 3D
polymer scaffolds, gene expression profiles were stratified
by degeneration status. The expression levels of extracellu-
lar matrix marker genes found in AF cells cultured in poly-
mer scaffolds were compared to levels found in monolayer
cultures (Figure 4). 3D assembly of expanded AF cells
derived from slightly degenerated annulus fibrosus tissue in
polymer scaffolds resulted in significant induction (p < 0.05)
of the expression levels of aggrecan (up to FC = 7.8 at day
21), decorin (up to FC = 6.5 at day 21), collagen type II
(FC = 83.4 at day 21), MMP2 (up to FC = 6.4 at day 21),
and MMP13 (FC = 89.4 at day 7 and FC = 47.2 at day 21),
compared to the expression levels found in expanded AF
cells in monolayer from slightly degenerated tissue. The
induction of the expression levels of aggrecan, decorin,
MMP2, and MMP13 in slightly degenerated AF cells in
3D polymer scaffolds was significantly higher than the in-
duction found in severely degenerated AF cells cultured in
3D polymer scaffolds, while the collagen type X induction
was significantly lower.Figure 4 Gene expression analysis of slightly and severely degenerat
stratified by degeneration status of AF cells and are given for slightly and s
PGA-PLGA-PVDF scaffolds (3D) for up to 21 days. Fold changes of genes co
given compared to their expression level found in monolayer expanded AF
indicate significant differential expression (p < 0.05) compared to monolaye
(p < 0.05) compared to severely degenerated AF cells.Severely degenerated AF cells cultured in 3D polymer
scaffolds showed significant induction of the expression
levels of aggrecan (FC = 2.9 at day 21), biglycan (FC = 2.8
at day 21), decorin (FC = 2.2 at day 21), collagen type II
(FC = 146.5 at day 21), and MMP13 (up to FC = 21.7 at
day 21), compared to severely degenerated AF cells
cultured in monolayer. At day 7, but not at day 21, the
expression of collagen type I was significantly reduced
in severely degenerated AF cells in 3D polymer scaffolds
(FC = −2.6), compared to monolayer controls.
Discussion
The PGA-PLGA-PVDF scaffold under investigation in
this study showed good biocompatibility in terms of AF cell
viability in 3D culture after 7 and 21 days. Progressive deg-
radation of the absorbable scaffold components, however,
was already observed as early as day 7. In conjunction with
the observation of low AF protein deposition, deduced
from the weak staining results of characteristic matrix
molecules, it is unclear, whether this construct would be
biomechanically stable enough to facilitate AF repair in
a clinical application. Several biomaterials have been
suggested for AF repair that, in general, showed good
biocompatibility with AF cells in vitro [10]. With regard
to absorbable biomaterials, however, optimal absorption
time with associated biomaterial stability has not beened AF cells cultured in 3D scaffolds. Gene expression data were
everely degenerated AF cells cultured in monolayers and in
ding extracellular matrix molecules and matrix modifying enzymes are
cells. Bars show the mean and standard deviation. Asterisks (*)
r cultures. Number sign (#) indicate significant differential expression
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we found a general differentiation of the expanded ded-
ifferentiated AF cells toward a cartilaginous expression
profile. But the more pronounced expression of aggre-
can and type II collagen is actually more suggestive for
nucleus pulposus-like tissue than for AF tissue. This is
probably the result of missing biomechanical forces
in vitro. Several studies indicate that especially intermit-
tent loading patterns on AF cell cultures can modulate
more characteristic AF expression profiles [21,22].
In patients with degenerative disc diseases, slightly and
severely degenerated intervertebral discs can be ob-
served. Here, we investigated if the grade of degener-
ation influences the gene expression profile in our 3D
culture system. Characteristic matrix molecules type I,
II and III collagen as well as aggrecan were assessed by
gene expression analysis. The large proteoglycan aggre-
can that provides a water-retaining chemical structure
for the intervertebral disc was expressed in significantly
higher amounts in AF cells from slightly degenerated
discs compared to AF cells from severely degenerated discs.
Collagen type I, II and III, however, did not display any dif-
ferences in this regard. In addition, the small proteoglycans
biglycan and decorin were assessed. These bind to colla-
gens, growth factors, and other matrix components and
thereby appear to regulate the assembly of matrix and to
influence repair processes after injury [7,23]. In this study,
Decorin, but not Biglycan, displayed significant higher gene
expression levels in AF cells from slightly degenerated discs.
A potentially undesirable response is type X collagen ex-
pression, which is a marker for chondrocyte hypertrophy
that might lead to tissue calcification or even ossification
[24]. Type X collagen expression of AF cells from slightly
degenerated tissue was found to be significantly lower than
in AF cells from severely degenerated discs. The matrix
metalloproteinases MMP-2 and MMP-13 were previously
found to be involved in degenerative processes of the
intervertebral disc [25,26]. Here, they were analyzed to as-
sess catabolic processes. We observed significantly higher
expression levels of MMP-2 and MMP-13 in AF cells from
slightly degenerated discs compared to AF cells from se-
verely degenerated disc. It is not clear, however, whether
MMP induction in our 3D culture system is an undesirable
effect or part of a natural balancing response to the induced
anabolic processes that, in general, appeared to be more
pronounced in AF cells from slightly degenerative discs.
TGF-beta has shown promising results as an anabolic
factor for AF cells in vitro [11,27]. In in vivo applications,
however, growth factors maintain effective concentrations
only for a very limited amount of time. We hypothesized
that an initial boost with TGF-beta could induce a lasting
effect of superior cartilaginous differentiation that could
even be further enhanced with hyaluronan. Hyaluronan is
a major component of the intervertebral disc matrix thatwas shown to support chondrogenic differentiation of
mesenchymal stem cells in previous reports [28,29]. In
this 3D culture system, however, an initial boost of
TGF-beta 1 with or without hyaluronan did not enhance
anabolic gene expression profiles and failed to induce a
superior cartilaginous matrix formation. A weakness of
this study is that we tested only one growth factor in
one concentration. Higher concentrations for the initial
boost might yield better results but also carry the risk of
undesired neurological complications in vivo [30]. Other
possible strategies to provide longer lasting effects of
bioactive factors in vivo could be growth factor releasing
systems [13,31], gene therapeutic approaches, or simply
a longer pretreatment with bioactive factors in vitro.
Conclusions
We failed to show a supportive effect of an initial boost
with TGF-beta 1 for AF cell differentiation and tissue
formation in our 3D culture system. This underlines the
need for further investigations on growth factor releas-
ing systems. Expanded AF cells from severely degener-
ated intervertebral disc tissues revealed the capacity to
re-differentiate toward a cartilaginous gene expression
profile in 3D culture and displayed only minor inferiority
compared to AF cells from slightly degenerated tissue in
this regard. This might qualify AF cells from severely
degenerated tissue to be also considered for cell-based
therapeutical approaches.
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